Research use only. All compounds are for laboratory research. Not for human or veterinary use. 21+.

Selank, 5 mg

Lot VA-2512-9985, analysed 2026-05-16

Traceability. The analytical report behind this certificate names the manufacturing lot, and the vials sold under VA-2512-9985 were filled from it. The lot identifier itself stays internal: it is shared with every brand the manufacturer fills for, and publishing it would let anyone match this material to a certificate issued under another name.

Results

TestSpecificationResultStatus
Appearance Visual inspection (Vantage Aminos)White lyophilized powderConformsPASS
Identity HPLC-UV-MS, positive polarity (+MS)Theoretical mass ± 1.0 Da751.51 Da (theor. 751.43)PASS
Purity HPLC-UV, area % · DAD 210.1-396.6 nm≥ 98.0 %99.70 %PASS
Quantity Quantitation as reported90-110 % of label (5 mg)4.894 mg (97.9 % of label)PASS
Largest single impurity HPLC-UV, area %Report0.3 % at 7.01 minREPORT
Water content Karl Fischer titration≤ 8 % w/w4.32 % w/wPASS

Open the certificate (PDF, opens in a new tab) Go to Selank All batch records

Identity and handling

Specimen readout VA-SELANK-5MG
CAS
129954-34-3
FORMULA
C33H57N11O9
MOL. WEIGHT
751.9
SEQUENCE
Thr-Lys-Pro-Arg-Pro-Gly-Pro
FORM
Lyophilized powder
FILL
5 mg
CONTAINER
3 mL vial
MANUFACTURED
2026-04-28
FILLED
2026-05-12
ANALYSED
2026-05-16
RETEST BY
2028-04-28
STORAGE
Refrigerated, 2-8 °C, protected from light
DOCUMENT
COA-VA-2512-9985 rev 1.1

Method

  • Technique Reverse-phase HPLC with UV detection, MS confirmation
  • Detection 210.1-396.6 nm (DAD range, not a single wavelength)
  • MS technique HPLC-UV-MS (as printed on certificate)
  • Ionisation Positive polarity (+MS)
  • Scan range m/z 48.2 - 1997.5 (as plotted)
  • Theoretical mass 751.43 Da
  • Observed mass 751.51 Da
  • Deviation +0.08 Da

Column, mobile phases, gradient, flow rate and injection volume are not stated on the laboratory report and are therefore not listed.

For research use only. Not for human or veterinary use. Not approved by the FDA. 21+